Brazil approves imports of Russia's Sputnik V, India's Covaxin vaccines

1 minute read

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi//File Photo/File Photo

BRASILIA, June 4 (Reuters) - Brazilian health regulator Anvisa on Friday voted to approve imports of Russia's Sputnik V and India's Covaxin COVID-19 vaccines, but with conditions on both.

The 4-1 vote by Anvisa's board follows rulings in April to reject Brazilian states' request for Sputnik V due to a lack of data guaranteeing its safety, quality and effectiveness, and in March to reject Covaxin because it did not meet Anvisa's manufacturing standards.

Reporting by Jamie McGeever and Alexandre Caverni; Editing by Leslie Adler

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters